Sera Prognostics, Inc. - Class A Common Stock (SERA)

About Sera Prognostics, Inc. - Class A Common Stock (SERA)

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Sera Prognostics, Inc. - Class A Common Stock News